Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients

Abstract

The use of cationic and ionizable cationic lipids in pharmaceutical products, however, is a double-edged sword, as these excipients are of considerable safety concerns. Because of their permanent or pHdependent cationic nature, they perturbate cellular and nuclear membranes, trigger the release of degrading enzymes from lysosomes, cause mitochondrial permeabilization and dysfunction, generate reactive oxygen species (ROS), alter cytoplasmatic enzyme functions, and damage DNA. [3] To address this substantial shortcoming of cationic and ionizable cationic lipids, biodegradable alternatives have been introduced that are rapidly degraded in vivo to preferably endogenous metabolites. The design of such lipids is inspired by natural cationic or ionizable cationic compounds like arginine, lysine or betaine that are generally regarded as safe. Their conjugation to endogenous lipids like fatty acids or cholesterol results in amphiphilic lipids. As ester and amide bonds are cleaved in vivo by numerous enzymes such as lipases, esterases, and proteases, they are the preferred linkages between these natural building blocks.Since the FDA approved ethyl Nα-lauroyl-l-arginate as biodegradable food preservative being effective against a broad range of Gram-positive and Gram-negative bacteria, yeasts, and molds in 2005, [4] the potential use of biodegradable cationic and ionizable cationic lipids as pharmaceutical excipients has been evaluated by numerous research groups. As these excipients exhibit the same properties as their non-biodegradable counterparts but causing relatively low adverse effects, they will likely substitute currently used non-biodegradable lipids in the future. Within this review, we provide an overview on the different types of biodegradable cationic and ionizable cationic lipids, their synthesis and cleavage by endogenous enzymes. Applications in drug delivery systems and as antimicrobial agents are discussed. A guideline on their design and application is provided and an outlook on future developments is given. Building Blocks and Formation of Cationic and Ionizable Cationic LipidsGenerally, biodegradable cationic and ionizable cationic lipids are composed of biocompatible building blocks that are conjugated via a linkage such as an ester or amide bond. [5] Representative building blocks and linkages are depicted in Figure 1. Endogenous enzymes can break these linkages and degrade Cationic and ionizable cationic lipids are broadly applied as auxiliary agents, but their use is associated with adverse effects. If these excipients are rapidly degraded to endogenously occurring metabolites such as amino acids and fatty acids, their toxic potential can be minimized. So far, synthesized and evaluated biodegradable cationic and ionizable cationic lipids already showed promising results in terms of functionality and safety. Within this review, an overview about the different types of such biodegradable lipids, the available building blocks, their synthesis and cleavage by endogenous enzymes is provided. Moreover, ...

Delineating effect of cationic head group and preparation method on transfection versus toxicity of lipid-based nanoparticles for gene delivery

“…They found that SM-102 and its degradation products rapidly eliminate from the body owing to the linear fatty alcoholic tail present in its chemical structure that is highly accessible for enzymatic cleavage of ester bonds (27). This completely supports our ndings where SM-102 was observed to be the safest ionizable lipid in terms of biocompatibility as well as hemocompatibility amongst all formulations.…”

Trehalose-based coacervates for local bioactive protein delivery to the central nervous system

“…Irrespective of these minor initial variations, all coacervate formulated at this concentration (10 mg/ml) coalesced into a bulk liquid phase within 30 minutes (Figure 2C). Based on these data and the understanding that the ionizable carboxylate and tertiary amine chemical functionalities are likely to be bet-ter tolerated in vitro and in vivo 49,50 , we opted to explore coacervates derived from oligo-mers end-capped with C and D functionality for the remainder of the studies reported here.…”

A Perspective of Engineered Lipids and Liposomes: Chemical Design and Functional Application Based on Therapeutic Safety

“…44−46 To solve the cytotoxicity challenge associated with cationic liposomes and LNP, researchers have further developed ionizable lipids. 44 Ionizable lipids are a class of compounds, characterized by a pK a range of 6−7, where the hydrophilic headgroup of lipid molecules is the amino group. The amino group is positively charged upon protonation under the environment with a pH lower than 4.0 and can be combined with negatively charged genes to achieve effective payload, while also aiding in their escape from endosomes and lysosomes.…”

“…This discovery is of decisive significance for the study of liposome and LNP mediated gene transfection. However, the clinical application of cationic liposomes or LNP is somewhat restricted due to their adverse toxicity and suboptimal in vivo transfection efficacy. − To solve the cytotoxicity challenge associated with cationic liposomes and LNP, researchers have further developed ionizable lipids . Ionizable lipids are a class of compounds, characterized by a p K a range of 6–7, where the hydrophilic headgroup of lipid molecules is the amino group.…”

“…Chemical structures of polar heads and hydrophobic tails in common cationic lipids. Parts adapted with permission from ref . Copyright 2023 John Wiley and Sons.…”